Sign in
4

Changes in Ownership

Aligos Therapeutics, Inc. Filed Acc 0001610717-24-000370

Options or other derivatives

  • Director acquired 60,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Scopa James Paul · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-06-27 Grant or award : show line 1 in the form Stock Option (Right to Buy) +60,000 60,000 D
Loading xslF345X05/form4.xml…